{"id":75860,"date":"2026-04-16T09:07:31","date_gmt":"2026-04-16T07:07:31","guid":{"rendered":"https:\/\/www.cigarjournal.com\/?p=75860"},"modified":"2026-04-16T09:07:31","modified_gmt":"2026-04-16T07:07:31","slug":"judge-issues-final-ruling-on-premium-cigar-definition","status":"publish","type":"post","link":"https:\/\/www.cigarjournal.com\/de\/judge-issues-final-ruling-on-premium-cigar-definition\/","title":{"rendered":"Judge Issues Final Ruling on Premium Cigar Definition"},"content":{"rendered":"<p>Judge Amit P. Mehta\u00a0issued a ruling\u00a0that finally resolves Cigar Rights of America\u2019s (CRA) long-fought battle against the U.S. Food &amp; Drug Administration\u2019s (FDA) overregulation with an unprecedented and total win for our industry. The judge has decided that premium cigars will remain outside the scope of FDA regulation at this time and that the exemption will apply only to truly premium products.<\/p>\n<p>Today\u2019s ruling adopts a definition of \u201cpremium cigar\u201d first articulated by Judge Mehta in his August 2023 decision, a definition supported by CRA and the Premium Cigar Association (PCA) and later acknowledged by FDA. The ruling marks the final chapter in a series of court proceedings that began after Judge Mehta vacated FDA\u2019s application of its tobacco regulatory framework to premium cigars\u00a0in August of 2023, finding that the agency failed to justify treating premium cigars the same as mass-market tobacco products.\u00a0Importantly, Judge Mehta\u2019s conclusion in that decision rested on the administrative record shaped by CRA\u2019s\u00a0sustained leadership and advocacy during the FDA\u2019s rulemaking process, which the court relied upon in its landmark decision to vacate the agency\u2019s regulatory authority over premium cigars.<\/p>\n<p>This determination further highlights that lasting regulatory clarity is achieved through consistent evidence-based participation in the administrative process. Judge Mehta\u2019s reliance on the established record reaffirms that durable legal outcomes are not shaped by eleventh-hour fillings, but by years of substantive engagement.<\/p>\n<p>This latest decision conclusively affirms what CRA has long demonstrated through years of regulatory comments, direct engagement with FDA and the Center for Tobacco Products leadership, and sustained advocacy before Congress, that premium cigars constitute a distinct category of tobacco products warranting separate regulatory treatment from cigarettes and other mass-produced tobacco products.<\/p>\n<p>\u201cThis ruling provides long-overdue clarity for the industry, regulators, and lawmakers,\u201d said Mike Copperman, Executive Director of CRA. \u201cAfter nearly two decades of litigation and advocacy, the courts have definitively recognized what science, history, and common sense have long established, that premium cigars are fundamentally different.\u201d<\/p>\n<p>\u201cThis outcome validates the evidence-based arguments CRA has advanced for years,\u201d said Gary Pesh, President of CRA\u2019s Board. \u201cIt reinforces that regulatory policy must be grounded in data, not ideology, and that one-size fits-all tobacco regulation does not work.\u201d<\/p>\n<p>With the question of what is a premium cigar now resolved, this ruling provides a strong foundation for legislative and regulatory clarity at both the federal and state levels. Lawmakers now have clear judicial guidance as they consider statutory definitions, tax policy, and the appropriate regulatory treatment of premium cigars.<\/p>\n<p>\u201cThis decision ensures that family-owned manufacturers, small business retailers, and adult consumers are no longer left in regulatory limbo. This historic victory could not have been accomplished without the tireless dedication of CRA and its steadfast membership,\u201d Pesh added.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Judge Amit P. Mehta\u00a0issued a ruling\u00a0that finally resolves Cigar Rights of America\u2019s (CRA) long-fought battle against the U.S. Food &#038; Drug Administration\u2019s (FDA) overregulation with an unprecedented and total win for our industry.<\/p>\n","protected":false},"author":21,"featured_media":75861,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false},"categories":[177,49,55,44],"tags":[10182],"_links":{"self":[{"href":"https:\/\/www.cigarjournal.com\/de\/wp-json\/wp\/v2\/posts\/75860"}],"collection":[{"href":"https:\/\/www.cigarjournal.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cigarjournal.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cigarjournal.com\/de\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cigarjournal.com\/de\/wp-json\/wp\/v2\/comments?post=75860"}],"version-history":[{"count":1,"href":"https:\/\/www.cigarjournal.com\/de\/wp-json\/wp\/v2\/posts\/75860\/revisions"}],"predecessor-version":[{"id":75863,"href":"https:\/\/www.cigarjournal.com\/de\/wp-json\/wp\/v2\/posts\/75860\/revisions\/75863"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cigarjournal.com\/de\/wp-json\/wp\/v2\/media\/75861"}],"wp:attachment":[{"href":"https:\/\/www.cigarjournal.com\/de\/wp-json\/wp\/v2\/media?parent=75860"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cigarjournal.com\/de\/wp-json\/wp\/v2\/categories?post=75860"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cigarjournal.com\/de\/wp-json\/wp\/v2\/tags?post=75860"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}